TGFbeta-IN-2, CAS [[2387678-02-4]]

Produktübersicht

• Artikelname: TGFbeta-IN-2, CAS [[2387678-02-4]]
• Artikelnummer: MCE-HY-146434
• Hersteller Artikelnummer: HY-146434
• Alternativnummer: MCE-HY-146434-10MG,MCE-HY-146434-5MG,MCE-HY-146434-50MG,MCE-HY-146434-25MG,MCE-HY-146434-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

TGFbeta-IN-2 is an orally active TGF-beta inhibitor. TGFbeta-IN-2 suppresses the TGF-beta-induced protein expression of COL1A1, alpha-SMA, and p-Smad3 in vitro. TGFbeta-IN-2 demonstrates excellent anti-fibrotic efficacy in Bleomycin (HY-108345)-induced pulmonary fibrosis model. TGFbeta-IN-2 can be used for the study of pulmonary fibrosis[1].

Produkteigenschaften

• Molekulargewicht: 378.42
• Reinheit: 99.37
• CAS Nummer: [2387678-02-4]
• Formel: C22H22N2O4
• Target-Kategorie: TGF-beta/Smad

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound